AI Diagnostic Platform Company Noul Enters Cancer Diagnostic Business with the Launch of Cervical Cell Analysis Product

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

Noul-Cancer-Business

More Like This

PR Newswire associated0

On-Device AI Healthcare Company Noul Becomes First Korean Diagnostic Company to Join Swiss Malaria Group

PR Newswire associated0

Noul and Limbach Gruppe, Germany's top lab chain, to sign an agreement for the supply of miLab™ BCM

PR Newswire associated0

/C O R R E C T I O N -- Menarini Silicon Biosystems/

Diagnostics.ai Launches Industry's First CE-IVDR Certified Transparent AI Platform for Molecular Diagnostics as Regulatory Deadlines take Effect

Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness with the Initiation of CERo Therapeutics Phase 1 Clinical Trial

NEC Laboratories Europe and Data-Driven.AI enhance AI medical diagnosis to improve the early detection of disease and illness

PR Newswire associated0

A. Menarini Diagnostics and Nucleix announce a strategic partnership for a non-invasive bladder cancer test in Europe

CleanNA Enters the Molecular Diagnostics Market by Launching Its First CE-IVD Product